Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

May
23
2022

Correction: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

BOCA RATON, Fla, May 23, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will…

May
18
2022

Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

BOCA RATON, Fla, May 18, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will…

May
05
2022

Sensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237%

Diluted EPS from operations of $0.20 compare with $(0.07) in the year-ago quarter Affirms expectations for continued growth in the second quarter and full year profitability Conference call begins at 4:30 p.m. Eastern time today…

April
21
2022

Sensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022

BOCA RATON, Fla, April 21, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy